These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21159603)

  • 1. Genome-wide mRNA and microRNA profiling of the NCI 60 cell-line screen and comparison of FdUMP[10] with fluorouracil, floxuridine, and topoisomerase 1 poisons.
    Gmeiner WH; Reinhold WC; Pommier Y
    Mol Cancer Ther; 2010 Dec; 9(12):3105-14. PubMed ID: 21159603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel polypyrimidine antitumor agent FdUMP[10] induces thymineless death with topoisomerase I-DNA complexes.
    Liao ZY; Sordet O; Zhang HL; Kohlhagen G; Antony S; Gmeiner WH; Pommier Y
    Cancer Res; 2005 Jun; 65(11):4844-51. PubMed ID: 15930305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines.
    Suetsugu T; Mori R; Futamura M; Fukada M; Tanaka H; Yasufuku I; Sato Y; Iwata Y; Imai T; Imai H; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yoshida K
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced DNA-directed effects of FdUMP[10] compared to 5FU.
    Gmeiner WH; Trump E; Wei C
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):401-10. PubMed ID: 15043163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-load nanoparticles with a chemotherapeutic SN-38/FdUMP drug cocktail.
    Sabljo K; Ischyropoulou M; Napp J; Alves F; Feldmann C
    Nanoscale; 2024 Aug; 16(31):14853-14860. PubMed ID: 39034735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities.
    Liu H; D'Andrade P; Fulmer-Smentek S; Lorenzi P; Kohn KW; Weinstein JN; Pommier Y; Reinhold WC
    Mol Cancer Ther; 2010 May; 9(5):1080-91. PubMed ID: 20442302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors.
    Kurtzberg LS; Battle T; Rouleau C; Bagley RG; Agata N; Yao M; Schmid S; Roth S; Crawford J; Krumbholz R; Ewesuedo R; Yu XJ; Wang F; Lavoie EJ; Teicher BA
    Mol Cancer Ther; 2008 Oct; 7(10):3212-22. PubMed ID: 18852125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variants of Drosophila melanogaster Cyp6d2 cause camptothecin sensitivity and synergize with loss of Brca2.
    Thomas AM; Hui C; South A; McVey M
    G3 (Bethesda); 2013 Jan; 3(1):91-9. PubMed ID: 23316441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication-dependent irreversible topoisomerase 1 poisoning is responsible for FdUMP[10] anti-leukemic activity.
    Jennings-Gee J; Pardee TS; Gmeiner WH
    Exp Hematol; 2013 Feb; 41(2):180-188.e4. PubMed ID: 23085462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of FdUMP[10] in treatment of HT-29 human colon cancer xenografts.
    Liu C; Willingham M; Liu J; Gmeiner WH
    Int J Oncol; 2002 Aug; 21(2):303-8. PubMed ID: 12118325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair and resistance to topoisomerase I inhibitors: mechanisms, biomarkers and therapeutic targets.
    Alagoz M; Gilbert DC; El-Khamisy S; Chalmers AJ
    Curr Med Chem; 2012; 19(23):3874-85. PubMed ID: 22788763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique dual targeting of thymidylate synthase and topoisomerase1 by FdUMP[10] results in high efficacy against AML and low toxicity.
    Pardee TS; Gomes E; Jennings-Gee J; Caudell D; Gmeiner WH
    Blood; 2012 Apr; 119(15):3561-70. PubMed ID: 22362039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU.
    Liu J; Skradis A; Kolar C; Kolath J; Anderson J; Lawson T; Talmadge J; Gmeiner WH
    Nucleosides Nucleotides; 1999 Aug; 18(8):1789-802. PubMed ID: 10478484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibition.
    Bijnsdorp IV; Comijn EM; Padron JM; Gmeiner WH; Peters GJ
    Oncol Rep; 2007 Jul; 18(1):287-91. PubMed ID: 17549381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA expression profiling in multidrug resistance of the 5‑Fu‑induced SGC‑7901 human gastric cancer cell line.
    Wang Y; Gu X; Li Z; Xiang J; Jiang J; Chen Z
    Mol Med Rep; 2013 May; 7(5):1506-10. PubMed ID: 23525256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted drug delivery to chemoresistant cells: folic acid derivatization of FdUMP[10] enhances cytotoxicity toward 5-FU-resistant human colorectal tumor cells.
    Liu J; Kolar C; Lawson TA; Gmeiner WH
    J Org Chem; 2001 Aug; 66(17):5655-63. PubMed ID: 11511236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecan.
    Meisenberg C; Ashour ME; El-Shafie L; Liao C; Hodgson A; Pilborough A; Khurram SA; Downs JA; Ward SE; El-Khamisy SF
    Nucleic Acids Res; 2017 Feb; 45(3):1159-1176. PubMed ID: 28180300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Homocamptothecins--novel promising anticancer drugs as inhibitors of topoisomerase I].
    Yang S; Zhang WN
    Yao Xue Xue Bao; 2004 May; 39(5):396-400. PubMed ID: 15338888
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitumor activity of alkylesters of 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP) against murine lymphoma L5178Y resistant to 5-fluoro-2'-deoxyuridine.
    Kanzawa F; Matsushima Y; Ishihara J; Hoshi A; Ohba T; Watanabe K
    J Pharmacobiodyn; 1986 Aug; 9(8):688-93. PubMed ID: 2946859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors.
    Tomicic MT; Kaina B
    Biochim Biophys Acta; 2013 Jan; 1835(1):11-27. PubMed ID: 23006513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.